))
Diagnosing amyloidosis, currently available therapies & the importance of cardio-oncology
Manage episode 405160228 series 2838329
Content provided by VJHemOnc. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by VJHemOnc or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
While there have been advances in the treatment and management of amyloidosis in recent years, diagnosis remains a challenge due to the highly varied presentation of this disease. As clinicians and researchers work to improve outcomes for patients, there is increasing importance being placed on the role of the multidisciplinary team in treating these patients.
In this podcast, you will hear from Morie Gertz, MD, MACP, Mayo Clinic, Rochester, MN, Ashutosh Wechalekar, MBBS, MD, FRCP, FRCPath, DM, University College London Hospitals NHS Foundation Trust, London, UK, and Daniel Lenihan, MD, FACC, Saint Francis Health System, Cape Girardeau, MO, who discuss the significant role of cardio-oncology in amyloidosis, currently available therapies, diagnostic approaches being explored, and more.
200 episodes
Share
